Skip to content

Clinical Application Research of 18F/68Ga/64Cu-FAPI PET Examination in Non-tumor Diseases with High Expression of FAP

Clinical Application Research of 18F/68Ga/64Cu-FAPI PET Examination in Non-tumor Diseases with High Expression of FAP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125170
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-05-21
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

There are non-tumor diseases with possible high expression of FAP, including but not limited to:(1) Inflammatory/immune disorders: Inflammatory bowel disease (IBD), IgG4-related diseases, rheumatoid arthritis, vasculitis.(2) Fibrotic diseases: Idiopathic pulmonary fibrosis (IPF), interstitial lung disease (ILD), liver fibrosis, retroperitoneal fibrosis.Cardiovascular system diseases: Ventricular r

Interventions

Gold Standard:Detection of FAP expression by pathological IHC method
Index test:18F/68Ga/64Cu-FAPI PET scan

Sponsors

Shanghai tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 18 - 75 years old. Gender: No restrictions. 2.Suspected presence of non-tumor lesions with high expression of FAP; 3.Expected survival period >= 6 months; 4. Understand the purpose of the study and the associated risks, voluntarily sign a written informed consent form, and demonstrate good compliance.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Those who were diagnosed with concurrent malignant tumors at the same time and whose conditions were not under control; 3.Severe restlessness, unable to cooperate for a long period (approximately 20 minutes) of quiet and lying still examination. 4.Severe liver and kidney dysfunction; 5.Those who are allergic to the components of the developer or have other contraindications;

Design outcomes

Primary

MeasureTime frame
Specificity;Accuracy;Sensitivity;

Countries

China

Contacts

Public ContactChao Ma

Shanghai tenth People's Hospital

ponymachao@163.com+86 187 2128 8964

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026